Search - tctmd.com

Displaying 361 - 380 of 709

Sort: Relevancy | Date

News Features

Wearables Under the Microscope: How New Tech Will Disrupt Patient-Physician Dynamics

Marcus A. Banks

August 15, 2019

News Daily News

A Boost for Prescription Omega-3s? Not Yet: FDA Panel Set for November

Yael L. Maxwell

August 14, 2019

News Daily News

Evidence Mounts for Plant-Based Diets in Preventing CVD

Yael L. Maxwell

August 13, 2019

News Daily News

Ideal CV Health at Age 50 Foretells Lower Risk of Later Dementia

Marcus A. Banks

August 12, 2019

News Daily News

Nighttime, 24-Hour BP Readings Have Strongest Link to Poor Outcomes

Todd Neale

August 06, 2019

News Daily News

Stricter Regulations Needed to Maximize Cuts in Sodium Intake, UK Study Suggests

Marcus A. Banks

July 22, 2019

News Daily News

Most Supplements and Diets Don’t Lower CVD or Mortality Risks

Michael O'Riordan

July 09, 2019

News Daily News

Weight Training, Aerobic Exercise Affect Cardiac Fat Mass in Different Ways

Michael O'Riordan

July 05, 2019

News Daily News

Elevated Non-HDL Cholesterol Levels Persist From Youth to Middle Age

Marcus A. Banks

July 03, 2019

News Industry News

U.S. FDA Grants Fast Track Designation to Empagliflozin for the Treatment of Chronic Heart Failure

June 26, 2019

News Daily News

To Battle CVD in China, the ‘Healthcare Pyramid’ Must Be Flipped

L.A. McKeown

June 25, 2019

News Daily News

Genetic Data Hint at Causal Link Between High BMI and Cardiovascular Diseases

Marcus A. Banks

June 24, 2019

News Industry News

Health Library: Hypertension (High Blood Pressure)

June 24, 2019

News Industry News

New Finnish Study: Dietary Cholesterol or Egg Consumption do not Increase the Risk of Stroke

May 20, 2019

News Conference News HRS 2019

Bariatric Surgery Tied to Less A-fib Recurrence After Ablation

Todd Neale

May 17, 2019

News Daily News

Residual Inflammatory Risk and PCI: Worthy Biomarker or Merely Something Else to Measure?

Yael L. Maxwell

May 15, 2019

News Industry News

BioTrace Medical’s Tempo Lead Obtains CE Mark for Safe and Secure Temporary Intracardiac Pacing

May 08, 2019

News Industry News

FDA approves new treatments for heart disease caused by a serious rare disease, transthyretin mediated amyloidosis

May 06, 2019

https://stock.adobe.com/images/african-american-girl-brushing-teeth-together-with-dad/247146126

News Daily News

Childhood Oral Infections Linked to Adult Atherosclerosis in Prospective Study

Yael L. Maxwell

April 29, 2019

News Daily News

PCSK9 Inhibitor Alirocumab Receives Expanded Indication for CV Event Reduction

Michael O'Riordan

April 29, 2019

Advertisement

Wearables Under the Microscope: How New Tech Will Disrupt Patient-Physician Dynamics

A Boost for Prescription Omega-3s? Not Yet: FDA Panel Set for November

Evidence Mounts for Plant-Based Diets in Preventing CVD

Ideal CV Health at Age 50 Foretells Lower Risk of Later Dementia

Nighttime, 24-Hour BP Readings Have Strongest Link to Poor Outcomes

Stricter Regulations Needed to Maximize Cuts in Sodium Intake, UK Study Suggests

Most Supplements and Diets Don’t Lower CVD or Mortality Risks

Weight Training, Aerobic Exercise Affect Cardiac Fat Mass in Different Ways

Elevated Non-HDL Cholesterol Levels Persist From Youth to Middle Age

U.S. FDA Grants Fast Track Designation to Empagliflozin for the Treatment of Chronic Heart Failure

To Battle CVD in China, the ‘Healthcare Pyramid’ Must Be Flipped

Genetic Data Hint at Causal Link Between High BMI and Cardiovascular Diseases

Health Library: Hypertension (High Blood Pressure)

New Finnish Study: Dietary Cholesterol or Egg Consumption do not Increase the Risk of Stroke

Bariatric Surgery Tied to Less A-fib Recurrence After Ablation

Residual Inflammatory Risk and PCI: Worthy Biomarker or Merely Something Else to Measure?

BioTrace Medical’s Tempo Lead Obtains CE Mark for Safe and Secure Temporary Intracardiac Pacing

FDA approves new treatments for heart disease caused by a serious rare disease, transthyretin mediated amyloidosis

Childhood Oral Infections Linked to Adult Atherosclerosis in Prospective Study

PCSK9 Inhibitor Alirocumab Receives Expanded Indication for CV Event Reduction

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content